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ABSTRACT 
A paradigm shift has taken place in which bone implant materials has gone from being 
relatively inert to having immunomodulatory properties, emphasizing the importance of 
immune response when these materials interact with the host tissues. It has therefore, become 
important to endow the implant materials with immunomodulatory properties favouring 
osteogenesis and osseointegration. Strontium, zinc and silicon are bioactive elements that 
have important roles in bone metabolism and that also elicit significant immune responses. In 
this study, Sr, Zn and Si-containing bioactive Sr2ZnSi2O7 (SZS) ceramic coatings on Ti-6Al-
4V were successfully prepared by a plasma-spray coating method. The SZS coatings 
exhibited slow release of the bioactive ions, with significantly higher bonding strength than 
hydroxyapatite (HA) coatings. SZS coated Ti-6Al-4V elicited significant effects on the 
immune cells, inhibiting the release of pro-inflammatory cytokines and fibrosis-enhancing 
factors, while upregulating the expression of osteogenic factors of macrophages. It could also 
inhibit the osteoclastic activities. The RANKL/RANK pathway, which enhances 
osteoclastogenesis, was inhibited by the SZS coatings, whereas the osteogenic differentiation 
of BMSCs was significantly enhanced by the SZS coatings/macrophages conditioned medium, 
probably via the activation of BMP2 pathway. SZS coatings are, therefore, a promising 
material for orthopaedic applications, and the strategy of manipulating the immune response 
by a combination of bioactive elements with controlled release has the potential to endow 
biomaterials with beneficial immunomodulatory properties. 
Key words: SZS coatings; bonding strength; osteogenesis; inflammatory reaction; 
osteoclastogenesis, macrophages, bone marrow derived mesenchymal cells (BMSCs) 
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1. INTRODUCTION 
The paradigm of the bone implant materials has shifted from being largely inert to having 
immunomodulatory properties and emphasizes the important role of immune responses during 
the biomaterial and host tissue interaction.
1
 Inappropriate material-mediated immune response, 
such as excessive inflammation, may lead to the formation of fibrous capsule, which prevents 
the bone cells from contacting and integrating with the implants and result in the failure of 
implants.
2
 As foreign bodies, implants will be recognised by the immune system, eliciting a 
foreign body reaction that may eventually form a fibrous capsule.  
In addition to excessive inflammation, the immune response was also found to play an 
important role in the integration and functioning of the biomaterial. With the emergence of 
osteoimmunology, the immune and skeletal systems are found to be closely related, sharing a 
number of cytokines, receptors, signalling molecules and transcription factors. It is found that 
the combination of all four cytokines, tumor necrosis factor alpha (TNFα), transforming 
growth factor beta (TGFβ), interferon gamma (IFNγ), and interleukin 17 (IL-17), at 
physiological concentrations, can induce mineralized matrix as effectively as dexamethasone 
(a commonly used osteogenic medium supplement), and the loss of any of these cytokines 
leads to the loss of osteogenesis.
3
 However, conditioned medium from lipopolysaccharide 
(LPS)-activated inflammatory M1 macrophages induced pre-osteoblast cells to differentiate 
towards fibroblasts even in the presence of osteogenic medium and this may be related to the 
upregulation of TNFα, IL-1β and IL-6.
4, 5
 It has also been shown that upregulation of IFNγ 
and TNFα by T lymphocytes can lead to the failure of MSCs based bone tissue regeneration 
and that these effects can be attenuated by the application of the anti-inflammatory drug 
aspirin.
6
 As for osteoclastogenesis, B cells are found to be the main source of bone marrow-
derived osteoprotegerin (OPG, a decoy receptor for RANK receptor), with a percentage of 
64%.
7, 8
 T-cells are thought to work cooperatively with B-cells and enhance OPG production 
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via CD40/CD40L co-stimulation.
7
 It is therefore of great interest and significance to endow 
materials with beneficial immunomodulatory properties for the development of advanced 
bone implant materials, so that the implanted biomaterial can facilitate an immune 
environment that is favourable for new bone regeneration and osseointegration.    
Many types of immune cells participate in the induced immune response, such as mast cells, 
lymphocytes, dendritic cells and macrophages. Of these, macrophages are considered the 
most important effector cells, which play a major role in determining the long-term immune 
response to materials and therefore the outcome of the inflammatory reaction.
9, 10
 In addition 
to their well-known effects on innate immune response, macrophages are also known to 
influence bone dynamics. As osteoclasts precursor cells, macrophages can differentiate into 
osteoclasts under osteoclastogenic condition, participating in the bone remodelling and 
material degradation. Macrophages also contribute to the osteogenesis, through the expression 
and secretion of a wide range of regulatory molecules, such as bone morphogenetic protein 2 
(BMP2), TGFβ, and vascular endothelial growth factor (VEGF).
11, 12
 Resident macrophages 
(osteomacs) are required for efficient osteoblast mineralization, and the depletion of 
macrophages leads to the complete loss of in vivo osteoblast-mediated bone formation.
13
 
Macrophages also release chemoattractants, such as chemokine (C-C motif) ligand 2 (CCL2) 
and CCL18, thereby participating in the recruitment of MSCs.
14
 Therefore, the response of 
macrophages was applied as an indicator of immune response in this study. 
Nutrient elements are of great physiological importance and the integration of nutrient 
elements in biomaterials, especially in bone implant materials, has been regarded as a sound 
strategy to endow biomaterials with improved bioactivity. For example, strontium (Sr) 
incorporated hydroxyapatite has been found to inhibit osteoclast activity and enhance 
ostegenesis, therefore expanding the application range of hydroxyapatite to patients with 
osteoporosis. Zinc (Zn) has been reported to have stimulatory effects on bone formation and 
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mineralization
15
 and physiologically Zn deficiency can lead to the retardation of bone 
growth.
16, 17
 Therefore, its incorporation into CaP biomaterials enhances their osteogenic 
capacity. Silicon (Si) is an essential trace element for metabolic processes associated with 
bone development,
18
 and is known to locate at active calcification sites during the early 
mineralization process of bone growth.
19
 Insufficient dietary Si in chicks will lead to 
deformities of the comb, skin, and bones, whereas dietary Si supplementation can inhibit the 
bone resorption in ovarectomized animals.
20
 Aqueous Si has been shown to enhance the 
proliferation, differentiation and collagen production of osteoblasts
21
 and the release of Si-
containing ionic products from bioactive glass, bioceramics and coatings show similar 
stimulating effects in the proliferation and differentiation of bone-forming cells.  
In addition to their effects on osteogenesis, Sr and Zn are also found to significantly affect the 
immune response. For example, Sr is found to suppress the expression of the pro-
inflammation cytokines,
22, 23
 whereas Zn-substituted ceramics can enhance the release of the 
anti-inflammatory cytokine IL-10, while reduce the expression of TNFα and IL-1β, which 
may be related the regulation of toll-like receptor 4 (TLR-4) pathway.
24-27
 Patients with 
inflammatory diseases, such as rheumatoid arthritis, are associated with low plasma Zn 
concentrations and exhibit increased TNFα levels.
28
 The supplementation of Zn can reverse 
such a pathological process.
29
 It is, therefore, pertinent to modify otherwise inert bone implant 
materials with nutrient elements to endow them with beneficial immunomodulatory properties, 
thus avoiding excessive inflammation, and inducing a balance between osteoclastogenesis and 
osteogenesis that is better suited for the osseointegration and functioning of the implant 
materials. 
Titanium is a commonly-used metal for the fabrication of bone implants and bioactive 
ceramic coatings are considered a feasible strategy to enhance its bioactivity. A number of 
bioactive ceramic coatings have been investigated, many of which have improved 
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bioactivity;
30, 31
 however, most efforts have focused on the osteogenic properties, vis-a-vis the 
interaction with bone cells but not the immune response, in spite of the  well-documented role 
of the latter during the osseointegration. In this study, we have sought to combine the 
potentially effective micronutrient elements (Sr, Zn and Si) into a bioceramic system, in an 
effort to impart beneficial immunomodulatory properties to the titanium metal substrate to 
modulate inflammation, osteoclastogenesis and enhance osteogenesis. We have recently 
prepared Sr2ZnSi2O7 (SZS) ceramics.
32
 In this study, the prepare SZS ceramics was further 
coated on the Ti-6Al-4V substratum via the plasma-spray method, for potential orthopaedic 
applications. The immunomodulatory property (including the inflammatory reaction, 
osteoclastogenesis and osteogenesis) and the possibly underlying mechanisms were 
systematically investigated. 
2. EXPERIMENTAL SECTION 
2.1 Preparation and characterization of SZS coatings on Ti-6Al-4V 
The SZS powders were synthesized by the solid-state reaction process using SrO, ZnO and 
SiO2 as raw materials according to our previous study.
32
 To improve powder flowability, a 
sinter-crushing method was used. Briefly, the synthesized SZS powder was pressed into 
tablets, sintered at 1300
o
C after which the sintered tablets were crushed and sieved by 200 and 
400 meshes to obtain SZS particles with diameter of 40-80 µm for further coating preparation. 
The particle with the size of 40-80 µm has the most favorable powder flowability for the 
preparation of SZS coatings. The SZS powders and reconstituted particles were characterized 
by scanning electron microscopy (SEM, JSM-6700 F, Tokyo, Japan) and X-ray diffraction 
(XRD, D8 advance, Bruker, Germany). 
To prepared SZS coatings, the reconstituted SZS particles were sprayed on Ti-6Al-4V disks 
with dimensions of 10×10×2 mm (Yantai Metallic Material Co., Ltd, Shanghai, China). Prior 
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to plasma spraying, the Ti-6Al-4V substrates were grit blasted, ultrasonically washed with 
ethanol and dried at 60
o
C. An atmosphere plasma spraying system (Sulzer Metco, Sulzer, 
Winterthur, Switzerland) was applied to fabricate SZS coatings, and the parameters for 
plasma sprayed SZS coatings were shown as following (argon plasma gas flow rate: 40 slpm, 
hydrogen plasma gas flow rate: 10 slpm, spray distance: 120 mm, argon powder carrier gas: 
3.5 slpm, current: 700A, voltage: 66 V). The surface and cross-section of the prepared SZS 
coatings was observed by SEM. The crystal phase composition of the prepared SZS coatings 
was characterized by XRD. HA coatings were fabricated by spraying commercial HA 
powders onto Ti-6Al-4V substrate according to the previous study
33
 and used as the control.  
2.2 Bonding strength and solubility of SZS coatings 
The bonding strength between SZS coatings and Ti-6Al-4V substrate was measured with a 
mechanical tester (Instron-5592, SATEC, New Jersey, USA) in accordance with American 
Society for Testing and Materials (ASTM) C-633 described previously.
34, 35
 In brief, 10 
cylindrical Ti-6Al-4V rods (diameter: 25.4 mm) were prepared. Half of the rods were spray 
coated with SZS (final coating mass: 0.0394 ± 0.0008 g), the other half were grit blasted. 
High-performance E-7 glue (Shanghai Institute of Synthetic Resin, Shanghai, China) was 
used to join the two rods (one with SZS coatings and the other grit blasted), and compressive 
stress applied to both ends to assure close contact, after which the rods were placed in an oven 
at 100 
o
C for 3 h to solidify the glue. The bonding strength was measured by a mechanical 
tester at a crosshead speed of 2 mm·min
-1
, and the average of five measurements was 
calculated for the bonding strength of SZS coatings with the Ti-6Al-4V substrate. 
To investigate the chemical stability of the SZS coatings, the samples were immersed in 
simulated body fluids (10 mL) and kept under shaking conditions at 37 
o
C for defined time 
periods. The ionic concentrations of Sr, Zn, Si, Mg, Ca and P ions in SZS-soaked buffer 
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solution were tested by inductively coupled plasma atomic emission spectroscopy (ICP-AES, 
Varian 715ES, California, USA).  
2.3 Cell culture 
Three cell types, the murine-derived macrophage cell line RAW 264.7 (RAW) cells, 
osteoclasts and BMSCs, were used in this study.
35
 RAW cell cultures were maintained in 
Dulbecco’s Modified Eagle Medium (DMEM, Life Technologies, Carlsbad, California, USA) 
supplemented with 5% fetal bovine serum (FBS, Thermo Scientific, Waltham, Massachusetts, 
USA), and 1% (v/v) penicillin/streptomycin (Life Technologies) (complete medium) at 37 ºC 
in a humidified CO2 incubator. The cells were passaged at approximately 80% confluence by 
scraping and expanded through two passages before being used for the study.  
Osteoclasts were derived from RAW cells following the protocol as previously described.
36
 In 
brief, RAW cells were seeded to the T25 flask and cultured in complete medium for three 
days, after which the medium was replaced with fresh complete medium supplemented with 
35 ng/ml of recombinant human receptor activator of nuclear factor kappa-B ligand (RANKL) 
(Millipore, Billerica, Massachusetts, USA). The medium was changed every 3 days and cells 
were allowed to differentiate into functional osteoclasts over a period of 21 days.  
BMSCs were isolated and cultured based on protocols according to our previous studies.
37, 38
 
Briefly, bone marrow was obtained from patients (50-60 years old) undergoing hip or knee 
replacement surgery with informed consent given by all donors and the procedure was 
approved by the Ethics Committee of Queensland University of Technology. Lymphoprep 
was added to isolate the mononuclear cells from the bone marrow by density gradient 
centrifugation (Axis-Shield PoC AS, Oslo, Norway). The obtained cells were seeded into the 
tissue culture flasks containing DMEM supplemented with 10% FBS and 1% 
penicillin/streptomycin and incubated at 37 ºC in a humidified CO2 incubator. The culture 
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medium was changed every 3 days until the primary mesenchymal cells reached 80% 
confluence. The unattached hematopoietic cells were removed through medium change. The 
confluent cells were routinely subcultured by trypsinisation. Only early passage cells (p3–5) 
were used in this study. 
2.4 Ionic concentrations and the preparation of conditioned mediums 
SZS and HA coated Ti-6Al-4V were immersed in the complete medium with or without 
cultured RAW cells. After 3 and 6 days, the conditioned mediums were collected, and 
centrifuged at 1500 rpm for 20 min at 4 ºC to clear the supernatants, which were then mixed 
with 0.5% HNO3 at a ratio of 1:2 in preparation for the further ions concentration detection. 
The ionic concentrations of Sr, Si, Zn and Ca ions in complete culture medium, macrophages 
and osteoclasts conditioned mediums were quantified by ICP-AES . RAW cell conditioned 
mediums on day 3 were collected after clarified by centrifugation at 1500 rpm for 20 min. All 
the supernatants were then mixed with complete culture medium at a ratio of 1:2 to gain the 
RAW cells/coating materials conditioned mediums (CM), which were then kept in -80 ºC 
before further experiments. 
2.5 The growth of RAW 264.7 cells on SZS-coated Ti-6Al-4V 
RAW cells were seeded on the coating surface at a density of 10
5
/coating disk (10×10mm). 
The cells were incubated for 1 day, then a MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl 
tetrazolium bromide] assay was applied to test the overall metabolic activity. 50 µL of 5 
mg/mL MTT solution was added into each well then incubation for 4 hours. The DMEM-
MTT solution was carefully removed. Images were captured to document the formation of 
formazan crystal and then 100 µL of dimethyl sulfoxide (DMSO) was added to each well to 
dissolve the formazan crystals for quantitative assay. Absorbance was read at 495 nm on a 
microplate spectrophotometer (Benchmark Plus, Tacoma, Washington, USA). 
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For fluorescence microscopy, the cells were washed with cold PBS twice before being fixed 
in 4% paraformaldehyde (PFA) for 15 mins at room temperature (RT) and then washed twice 
with PBS to remove the PFA. The cells were permeabilized with 0.1% Triton/PBS for 20 
mins at RT. The cells were incubated in 1% BSA/PBS for 1 h and then 4',6-diamidino-2-
phenylindole (DAPI) and phalloidin with fluorescein isothiocyanate (FITC) were added at 
1:1000 and 1:250 dilution respectively to stain the nuclei and cytoskeletons and allowed to 
incubate in darkness for 20 min. Images were captured by confocal microscope (TCS SP5, 
Leica Microsystem, Solms, Germany).  
2.6 The inflammatory response of RAW 264.7 cells cultured on SZS-coated Ti-6Al-4V  
Inflammatory gene expression of RAW264.7 cells: RAW cells were seeded on coated surfaces 
at a density of 10
5
/disk (10×10mm). After 7 hours of culture, total RNA was extracted using 
TRIzol reagent (Life Technologies) for RT-qPCR detection and 500 ng of total RNA used for 
the synthesis of complementary DNA using DyNAmo
TM
 cDNA Synthesis Kit (Finnzymes, 
Thermo Scientific) following the manufacturer’s instructions.  The cDNA was stored in -20 
ºC for the further analysis of inflammatory and osteogenesis regulating gene expression. 
RT-qPCR primers (Supporting information Table 1), which were designed based on cDNA 
sequences from the NCBI Sequence database. SYBR Green qPCR Master Mix (Life 
Technologies, Carlsbad, California, USA) was used for detection and the target mRNA 
expressions (TNFα, IL-1β, IL-6, IFNγ, OSM, WNT5A, IL-10, and IL-1ra) were assayed on the 
ABI Prism 7500 Thermal Cycler (Applied Biosystems, Foster City, California, USA). The 
cycle threshold (Ct) value of each target gene was normalized against Ct value of a house 
keeping gene (GAPDH) to gain the relative expression. For the calculation of fold change, 
∆∆Ct method was applied, comparing mRNA expressions between SZS coating group and 
HA coating group. 
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Enzyme-linked immunosorbent assay (ELISA) of TNFα :Supernatants were collected from 
RAW cells cultured on HA and SZS coated Ti-6Al-4V in  previous section and the TNFα 
content was quantified using ELISA kits (R&D Systems, Minneapolis, Minnesota, USA) 
according to the manufacturer’s instruction. All experiments were performed in triplicate. The 
TNFα concentration was determined by correlation with a standard curve and the results were 
expressed as the amount (pg) of TNFα per ml of supernatant. 
2.7 Osteogenesis regulating gene expression of RAW 264.7 cells cultured on SZS-coated Ti-
6Al-4V 
The expressions of osteogenesis regulating genes macrophage colony-stimulating factor 
(MSCF), TGFβ1, TGFβ3, VEGF and BMP2 of RAW cells were detected by RT-qPCR, 
following the same method as previously described. cDNA used in this section was collected 
from previous section   and GAPDH was applied as housekeeping gene. 
2.8 The osteoclateogenesis and osteoclastic activities by the stimulation of SZS-coated Ti-6Al-
4V 
RAW cells were seeded on coated surfaces at a density of 10
5
/disk (10×10mm). The cells 
were incubated for 1 day and then stained by DAPI and Phalloidin with FITC as previously 
described, to observe the phagocytosis of the coating materials. Osteoclasts were seeded on 
the coated surfaces at a density of 10
5
/ disk. On day 3, total RNA was extracted using TRIzol 
reagent for detection of osteoclastic activities related gene expression tartrate-resistant acid 
phosphatase (TRAP), Cathepsin K (CTSK), Carbonic Anhydrase II (CA 2), receptor activator 
of NF-κB (RANK) and Calcitonin Receptor (CT), Matrix metalloproteinase-9 (MMP9)) as 
previously described. GAPDH was applied as housekeeping gene. 
Given that osteoblast cells are an important source of osteoclastogenesis regulating cytokines, 
we further used the macrophage-conditioned mediums to stimulate the BMSCs to assay the 
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gene expression changes of osteoclastogenesis regulating cytokines. BMSCs were seeded in 
the 6 well plates and cultured in complete medium. After 1 day of culture, the medium was 
replaced by the CMs obtained from previous section. After 7 days, total RNA was extracted 
using TRIzol reagent. RT-qPCR detection was carried out to determine the osteoclastogenesis 
regulating cytokines (MCSF, RANKL, and OPG) gene expression changes as previously 
described. GAPDH was applied as housekeeping gene. 
2.9 The osteogenic differentiation of BMSCs stimulated by RAW cells/coating materials 
conditioned mediums 
Bone-related gene and protein expression of BMSCs: BMSCs were plated at a density of 
20,000 cells per well in separate 6-well plates. After 24 hours of incubation, the culture 
medium was removed and replaced by CM. Cell morphology was observed under a Nikon's 
inverted microscope (Eclipse Ti, Nikon, Tokyo, Japan) and figures were taken. Total RNA 
was extracted using TRIzol reagent after 3 and 7 days of culture for detecting the expression 
of alkaline phosphatase (ALP), osteopontin (OPN), osteocalcin (OCN), collagen 1 (COL1) 
genes using RT-qPCR as previously described. GAPDH was applied as housekeeping gene. 
The whole cell lysates were collected after 14 days of culture, and analysed by Western blot.  
Fifteen micrograms of proteins from each sample were separated on SDS-PAGE gels and then 
transferred onto a nitrocellulose membrane (Pall Corporation, East Hills, New York, USA). 
The membranes were blocked in Odyssey blocking buffer for 1 hour (LI-COR Biosciences, 
Lincoln, Nebraska, USA), the membranes were incubated with primary antibodies against 
ALP (1:10,000, rabbit anti-human; Abcam, Cambridge, United Kingdom) and α-tubulin 
(1:5000, rabbit anti-human; Abcam) overnight at 4 °C. The membranes were washed three 
times in TBS-Tween buffer, and then incubated with anti- rabbit HRP conjugated secondary 
antibodies at 1: 4000 dilutions for 1 hour at room temperature. The protein bands were 
visualized using the Odyssey infrared imaging system (LI-COR Biosciences). The relative 
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intensity of protein bands was quantified using Image J software (National Institutes of Health, 
Bethesda, Maryland, USA). 
The mineralization of BMSCs: Mineralization nodules were visualised by Alizarin Red S 
staining on day 14 after BMSCs grown in CM in well plates with osteogenic supplements. 
The medium was removed and the cells were washed with ddH2O and fixed in 4% PFA for 10 
min at room temperature. After gently rinsing with ddH2O, the cells were stained in a solution 
of 2% Alizarin Red S at pH 4.1 for 20 min and were then washed with ddH2O. The samples 
were air-dried and images taken under a light microscope. 
Quantification of staining was done as previous described.
39
 In brief, 350 µL 10% acetic acid 
was added to each well, and the plate was incubated at room temperature for 30 min. The 
monolayer was then scraped from the plate and transferred with the acetic acid to a 1.5 mL 
microcentrifuge tube. After vortexing for 30 s, the slurry was overlaid with 300 µL mineral oil 
(Sigma-Aldrich, St. Louis, Missouri, USA), heated to 85 °C for 10 min, and transferred to ice 
for 5 min. The slurry was then centrifuged at 20,000 g for 15 min and 300 µL of the 
supernatant was removed to a new 1.5 mL microcentrifuge tube. Then 100 µL of 10% 
ammonium hydroxide was added to neutralize the acid. Aliquots (100 µL) of the supernatant 
were read in triplicate at the wavelength of 405 nm in 96-well plates using a microplate 
spectrophotometer. 
BMP2-related signalling pathway of BMSCs: BMSCs were plated at a density of 20,000 cells 
per well in separate 6-well plates. After 24 hours of incubation, the culture medium was 
removed and replaced by CM. Total RNA was extracted using TRIzol reagent after 3 days of 
culture. To investigate the activation of the BMP2 signalling pathway in BMSCs, BMP2 
signalling pathway related genes [Mothers against decapentaplegic homolog 1/4/5 (SMAD1, 
SMAD4, SMAD5), bone morphogenetic protein receptor, type IA (BMPR1A) and bone 
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morphogenetic protein receptor type II (BMPR2)] were analysed by RT-qPCR as previously 
described. 
2.10 Statistical analysis 
All the analyses were performed using SPSS software (IBM SPSS, Armonk, New York, 
USA). Data is shown as means ± standard deviation (SD) and analysed using one-way 
ANOVA followed by LSD post-hoc test. The level of significance was set at P<0.05. 
3. RESULTS 
3.1 Characterization, bonding strength and solubility of SZS particles and coatings  
The particle size of synthesized SZS powders was no more than 5 µm with irregular shapes 
(Fig. 1A). After reconstituted by sinter-crushing method, the SZS particles became larger in 
size (around 40-80 µm), with relatively regular shape (Fig. 1B). Although there were a few 
impurities of Sr2SiO4 phase in the SZS powders, the particles were pure with respect to the  
Sr2ZnSi2O7 crystal phase (Fig. 1C). The surface and cross-section morphology of the SZS 
coatings are shown in Figure 1D and 1E. The coatings had a dense surface that consisted of 
stacks of fully melted SZS particles (Fig. 1D). The thickness of the coatings was around 
100µm (Fig. 1E). XRD analysis showed that the main crystal phase of the SZS coatings was 
Sr2ZnSi2O7 with small amount of Sr2SiO4 (Fig. 1F). The mean bonding strength of the SZS 
coatings with Ti-6Al-4V substrate was 34.3±1.9 MPa.  
After soaking in a phosphate-buffered solution for 14 days, the SZS coatings showed no 
significant degradation (Fig. 2A). Sr and Si concentrations in the phosphate-buffered solution 
increased significantly after the first 2 days of soaking and then decreased over the duration of 
soaking time. Zn, Ca, P and Mg concentrations showed no significant changes during the 
whole soaking period (Fig. 2B). 
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3.2 The growth of RAW 264.7 cells on SZS-coated Ti-6Al-4V 
More formazan crystals were formed on the HA coated surfaces than the SZS surfaces, which 
was confirmed by the quantitative detection, showing that HA group had higher mean OD 
value (Fig. 3 A). Fluorescent microscopy revealed a similar trend that more RAW cells were 
observed on the HA coating surfaces than the SZS surfaces (Fig. 3 B, C). 
3.3 The inflammatory response of RAW 264.7 cells cultured on SZS-coated Ti-6Al-4V 
The pro-inflammatory genes TNFα, IFNγ, Oncostatin M (OSM) expression was significantly 
downregulated in RAW cells subjected to stimulation by the SZS coating compared with the 
HA coating group (Fig. 4 A, D, E, P<0.05).  TNFα ELISA result showed similar trend, with 
the decrease of TNFα released in the mediums (Fig. 4 I). However, IL- 6 gene expression was 
slightly increased, while IL-1β showed no significant change with same treatment (Fig. 4 B, 
C). The gene expression of the pro-inflammatory indicator WNT5A showed significant 
downregulation (Fig. 4 F, P<0.05), whereas the anti-inflammatory gene IL-10 was 
significantly upregulated by the stimulation of SZS coatings in comparison with the HA 
coating groups (P<0.05) (Fig. 4 G). IL-1ra, by contrast, was significantly downregulated with 
the same treatment (P<0.05) (Fig. 4 H).  
3.4 Osteogenesis regulating gene expression of RAW 264.7 cells cultured on SZS-coated Ti-
6Al-4V 
Both osteoclastogenesis-enhancing (MCSF) and fibrosis-enhancing (TGFβ1 and TGFβ3) 
factors were all significantly downregulated (Fig. 5 A, B, C, P<0.05). By comparison, the 
osteogenesis-enhancing factors VEGF and BMP2 were both significantly upregulated (Fig. 5 
D, E, P<0.05). 
3.5 The osteoclastic activities and osteoclastogenesis by the stimulation of SZS-coated Ti-6Al-
4V  
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RAW cells showed higher phagocytotic activity on the HA coated surfaces than on the SZS 
coated surfaces. The cells appeared to internalize the HA particles, forming a big “bubble” 
within the cytoplasma, which can be seen in most of the stimulated cells (Fig. 6 A, B). By 
contrast, this observation was not generally seen in the SZS coating stimulating RAW cells 
(Fig. 6 C, D). 
All osteoclast related genes (TRAP, CTSK, CAR2, RANK, and MMP9) by osteoclasts were 
significantly downregulated as a result of stimulation by the SZS coating compared with that 
of HA coating (Fig. 7 A). The expression of osteoclastogenesis enhancing gene RANKL by 
BMSCs was significantly downregulated (Fig. 7 B, P<0.05), while another osteoclastogenesis 
enhancing gene MCSF was slightly upregulated (Fig. 7 B, P<0.05). The expression of the 
osteoclastogenesis inhibiting gene OPG was significantly upregulated (Fig. 7 B, P<0.05).  
3.6 The osteogenic differentiation of BMSCs stimulated by RAW 264.7 cells/coating 
materials-conditioned mediums 
BMSCs grew well in both HA and SZS CM (Supporting information Fig. 1). Expression of 
two measured mineralization-related genes (OPN, COL1) by BMSCs stimulated by SZS CM 
were significantly upregulated compared to HA CM on both day 3 and day 7 (Fig. 8, P<0.05). 
Similarly, ALP gene expression was upregulated on day 3, and OCN gene expression was 
upregulated on day 7 (Fig. 8, P<0.05). However, ALP and OCN gene expressions showed no 
significant changes on day 3 and 7, respectively (Fig. 8, P>0.05). Western blot of ALP 
showed that ALP protein expression was significantly upregulated by BMSCs stimulated by 
SZS CM compared to HA CM (Fig. 9 A, P<0.05). 
Alizarin Red S staining showed evidence of calcium deposition and nodule formation. 
Mineralized nodules were observed in both groups with osteogenic medium (Fig. 9). More 
distinct nodules were observed in BMSCs stimulated by SZS CM compared to that of HA 
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CM, which was confirmed by the quantitative detection, which showed that the SZS group 
had higher absorbance value than the HA group  (Fig. 9 B, P<0.05). 
3.7 BMP2 signalling pathway-related gene expression 
To further explore the mechanism of the enhanced osteogenesis, we examined the gene 
expressions of BMP2 signalling pathways. The expressions of BMPR2, SMAD1, SMAD4 and 
SMAD5 in BMSCs cultured in SZS CM showed significantly upregulation compared to those 
cultured in HA CM (Fig. 10, P<0.05). However, the expression of BMP1A in BMSCs 
cultured in SZS CM was significantly downregulated compared to those cultured in HA CM 
(Fig. 10, P<0.05). 
3.8 Ionic concentrations of conditioned mediums 
Sr, Si and Zn ionic concentrations in the culture mediums were all significantly higher after 
soaking the SZS coated Ti-6Al-4V at both day 3 and 6 compared with that of HA coated Ti-
6Al-4V, independent of whether or not cells had been cultured on the disks (macrophages and 
osteoclasts) (Table 1). Sr concentrations showed the most significant increase, up to 
approximately 450 ppm. Si and Zn concentration were much lower, at around 60 and 45 ppm. 
Ca concentrations for the SZS groups were all lower than the HA groups (Table 1). 
4. DISCUSSION 
Bone biomaterials, such as titanium, can safely remain inside the body throughout life without 
triggering any significant immune response. However, such implants act simply as an “inert” 
mechanical support and can, therefore, not meet the specifications of an ideal bone 
biomaterial. For this reason it is of great importance to endow bone biomaterials with 
beneficial immunomodulatory properties, so that they can create a favourable immune 
environment to induce desired osseointegration and osteogensis. In this study, we have 
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attempted to endow Ti-6Al-4V with a immunomodulatory function by coating with nutrient 
elements-based Sr2ZnSi2O7 bioceramics. The induced immunomodulatory activities showed 
significant effects on the downregulation of inflammation, inhibition of osteoclastogenesis, 
and enhancement of osteogenesis (Figure 11).  
4.1 Nutrient elements released from the Sr2ZnSi2O7 coating 
According to the data sheet from the manufacturer, DMEM contains very few amounts of Sr, 
Zn and Si ions, and the major ions contained are Ca
2+
, Mg
2+
, K
+
, Na
+
, Cl
-
, PO4
3-
 etc. When 
SZS coating is in contact with culture medium, Sr, Zn, and Si ions are largely unsaturated in 
the solvent (culture medium), which leads to a relatively rapid releasing of Sr, Zn, and Si ions 
into the culture medium at the early stage of soaking.  
The molar ratio of Sr/Zn/Si in the immersed culture medium is around 7:1:3, different from 
the stoichiometric ratio (2:1:2), which may be due to the incongruent dissolution of Sr, Zn, 
and Si ions. SZS coating has a polycrystal structure and the dissolution is influenced by its 
crystal morphology and surface microstructure. Thus, the release of Sr, Zn and Si ions does 
not follow the stoichiometric ratio of material composition. In addition, due to the existence 
of surface microstructure deformities and unstable glass phase of SZS coatings, the 
dissolution rate of SZS coatings in DMEM is faster during the early stage, which may account 
for the higher Sr ion concentration at day 3 compared with that of day 6. It seems that Sr and 
Si dissolution are faster than for Zn, leading to the higher proportion of Sr and Si in the 
immersed culture medium.  
As to the long-term dissolution of SZS coating, the accumulative releasing rates of SZS 
coating over 14 days in SBF are Si: ~2.94%, Sr: ~5.78%, Zn ~0.90% (caltulated from Figure 
2 B). The releasing of Sr, Zn and Si shows different rate at the beginning (0-2 days Si: 
~1.81%, Sr: ~2.88%, Zn ~0.14%; 2-4 days Si: ~0.22%, Sr: ~1.16%, Zn ~0.14%). Sr has the 
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highest releasing rate while Zn has the lowest releasing rate. As time goes on (6-14 days), all 
three ions show slow releasing manner in a steady rate (Si: ~0.15%, Sr: ~0.3%, Zn ~0.12%), 
something which is important to eliciting a sustained effect on the surrounding cells and 
maintains the long-term useful life of implants. When the bioceramic coated implants are 
implanted in vivo, host body cells will be in contact with the coating materials first. The 
coating materials will then experience some degradation either by physicochemical 
dissolution, cell-medicated dissolution, hydrolysis, enzymatic decomposition, or corrosion.
40
 
The released ions or degraded particles from the coating are supposed to regulate the local 
microenvironment and determines the response and behaviour of host cells. It is therefore, 
vital to coat the titanium surface with bioactive materials that can create an environment 
favourable for the new bone formation, like SZS did in this study. To maintain the long-term 
life span of the implants, bioceramic coatings should have a slow release of bioactive ions at 
sufficient concentrations to assist osseointegration with the host bone tissue. Fast degradation 
would not provide sufficient time for the osseointegration, and might also result in adverse 
effects due to the high concentrations of releasing ions. In the present study, SZS had a 
greater ability to inhibit osteoclastogenesis than did HA, suggesting that SZS coatings may 
impose greater biological stability than does HA coatings.  
4.2 How do the released nutrient elements modulate the immune response? 
Zn is well known to be essential for the normal development and function of immune cells.
41
 
Zn deficiency will lead to the impairment of the production and signalling of inflammatory 
cytokines and thereby affect the immunological functions.
42, 43
 Plasma Zn concentration is 
maintained within a physiological range of 10-18 µmol/L (0.65-1.17 ppm) in homeostatic 
status.
43
 During an inflammatory response, the Zn homeostasis is restored with the Zn 
redistributed into the cellular compartment, resulting in the rapid clearing of plasma Zn 
concentration and an increase of inflammatory cytokines (TNFα, IL-1β, IL-6).
44, 45
 Low 
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plasma Zn concentration has become one common diagnostic feature of some inflammatory 
diseases (e.g. pneumonia and tuberculosis) and Zn supplementation (>45mg Zn/day) has been 
successfully applied as a therapeutic and preventive agent for these conditions, by decreasing 
the generation of pro-inflammatory cytokines.
41, 43
 SZS coating, which is effectively a large 
storage of Zn, has a slow release of Zn ions during the interaction between macrophages and 
the implants, and results in dampening the otherwise excessive inflammatory response to 
exogenous bodies.  
Zn affects the immune cells’ response in a concentration-dependent manner. It was found that 
the addition of Zn resulted in a concentration-dependent stimulation of TNFα (peaking at 250 
µmol/L (16.25 ppm)) and IL-1β (peaking at 120 µmol/L (7.8 ppm)) in peripheral blood 
mononuclear cells.
46
 In addition, 100 µmol/L (6.5 ppm) is supposed to be minimum 
concentration to inhibit the growth of peripheral blood mononuclear cells.
47
 Therefore, high 
concentration of Zn in the conditioned medium (45 ppm (690 µmol/L)) may be a key reason 
for the inhibition of macrophage growth and the dampening of the inflammatory response.  
Sr is known to stimulate osteogenesis and suppress osteoclastogenesis, with the underlying 
mechanism supposed to be related to antagonizing the activation of nuclear factor kappa-
light-chain-enhancer of activated B cells (NF-κB).
48
 NF-κB is known to play a key role in 
activating the inflammatory response, which suggests that Sr probably has some anti-
inflammatory effects. Some studies have been carried out to investigate whether introducing 
Sr into calcium phosphate based materials can modulate the immune response.
22, 49
 It has been 
found that Sr doped calcium phosphate can inhibit the release of pro-inflammatory cytokine 
TNFα compared with HA, at both high (around 500 µmol/L) and low (10 µmol/L) Sr ion 
concentrations.
22, 49
 IL-6, on the other hand, shows different expression patterns depending on 
Sr ion concentrations: at high concentration (around 500 µmol/L) Sr has a stimulatory effect 
on the release of IL-6,
49
 whereas the opposite effect was observed at a low Sr ion 
Page 20 of 43Journal of Materials Chemistry B
Jo
ur
na
lo
fM
at
er
ia
ls
C
he
m
is
tr
y
B
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
15
 Ju
ly
 2
01
4.
 D
ow
nl
oa
de
d 
by
 Q
ue
en
sla
nd
 U
niv
ers
ity
 of
 T
ec
hn
olo
gy
 on
 29
/07
/20
14
 03
:01
:16
. 
View Article Online
DOI: 10.1039/C4TB00837E
  
concentration (10 µmol/L).
22
 Our results showed that TNFα was inhibited and IL-6 was 
enhanced by SZS coating, which could be attributed to a high Sr concentration at 
approximately 450 ppm or 5.1 mmol/L.  
Ca is another element that is known to have modulatory effects on the immune response. One 
of the underlying mechanism is supposed to be related to the WNT5A/Ca
2+
 pathway, which is 
known to enhance the inflammation when activated.
50
 Wnt5A can bind to Fz5, activating the 
Wnt/Ca
2+
 signalling pathway via calmodulin-dependent protein kinase II (CaMKII) and 
protein kinase C, which activates the expression of downstream inflammatory cytokine genes 
via the NF-κB transcription factor.
50
 The culture medium showed a significant decrease of 
Ca
2+
 concentration after SZS coated implants had soaking in it. It is a reasonable to speculate 
that the decreased concentration of Ca
2+
 could be responsible for inhibiting the Wnt/Ca
2+
 
signalling pathway, resulting in the anti-inflammatory effects.  
Although the individual effect of each ion is well investigated, the synergistic effects of these 
ions are still largely unknown. Given both Zn and Sr have anti-inflammatory effects, it is 
reasonable to speculate that they can synergistically inhibit the inflammation under proper 
ionic concentrations. Our study demonstrated that the overall inhibitory effects of Zn (45 ppm 
(690 µmol/L)), Sr (450 ppm (5.1 mmol/L)), Si (58.86 ppm (2.1 mmol/L)) and Ca (43.05 ppm 
(1.08 mmol/L)) on inflammation. It seems the mixture of these ions (the ratio of Sr/Zn/Si is 
around 7:1:3) did not at least attenuate the original anti-inflammatory effects of Zn Sr and Ca. 
However, systemic study is required to find out whether the mixture of these ions at adequate 
concentration can synergistically modulate a favourable immune environment to enhance 
osteogenesis. 
As was pointed out in the introduction, inflammatory response is a key factor in determining 
the formation of fibrous capsule.
9, 10
 Excessive inflammation leads to the formation of fibrous 
capsule and can prevent the bone cells from contacting and integrating with the implants, thus 
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resulting in implant failure.
2
 The inhibition of an inflammatory response indicates that the 
SZS coatings are more compatible than HA coatings and may prevent the formation of fibrous 
capsule.   
4.3 The effects of the modulated immune environment on osteoclastogenesis 
The immune environment created by SZS coated Ti-6Al-4V appears to inhibit the osteoclastic 
activities and osteoclastogenesis. TRAP, CTSK, CA2, RANK, and MMP9 are recognised as 
markers of osteoclast activity. TRAP is highly expressed by osteoclasts and activated 
macrophages and its expression is increased when osteoclastic activity is enhanced. CTSK is 
a gene encodes a lysosomal cysteine protease involved in bone remodelling and resorption, 
which is expressed predominantly in osteoclasts. CA2 plays an important role in osteoclast 
differentiation and bone resorption by effecting the steady state intracellular pH and Ca
2+
. 
MMP9 is a protease involving in the breakdown of bone matrix. Therefore, the 
downregulation of these genes can well indicate that the osteoclatic activities were suppressed. 
The osteoclastogenesis is also known to be regulated by the RANKL/RANK/OPG pathway. 
RANKL binds to RANK, a receptor on the surface of osteoclast precursors, activating 
signalling through NF-κB, activator protein 1 (AP-1) and nuclear factor of activated T cells 2 
(NFAT2) to induce expression of genes for the survival and differentiation of osteoclasts.
51
 
OPG, a decoy receptor derived from osteoblasts, can bind to RANKL and interrupt its 
interaction with RANK receptor, thereby inhibiting osteoclastogenesis.
52, 53
 In addition, 
MCSF is another factor involved in the maturation of osteoclasts. MCSF binds to its receptor, 
c-fms, on osteoclast precursors and activates signalling through the protein kinase B and 
mitogen-activated protein kinases pathway.
54
 Osteoblastic cells are thought to be the major 
source of RANKL, MCSF and OPG, thus playing key role in regulating osteoclastogenesis. 
When compared to the HA coatings, it was found that SZS coatings could downregulate the 
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expression of RANKL gene, while upregulating the OPG expression of BMSCs, indicative of 
SZS coatings inhibiting osteoclastogenesis.  
The inhibitory effects of Sr in the RANKL/RANK system have been well documented. Sr is 
found to inhibit the differentiation of osteoclast in a concentration dependent manner (0-200 
µmol/L,
48
 0-24 mmol/L
55
), with higher concentration showing the most pronounced effect and 
thought to be related to the suppression of NFκB. The suppression of NFκB results in the 
downregulation of TNFα expression, and is implicated in the recruitment and differentiation 
of osteoclast precursors.
48
 Although IL-6 has been linked to osteoclast differentiation and 
activity, the present study did not reveal any association between the upregualtion of IL-6 and 
osteoclast activity. In fact, IL-6 has been observed to have an inhibitory effect on osteoclast 
differentiation, indicating a multifunctional role of this cytokine.
56
 In this study, the 
concentrations of the released Sr
2+
 in the macrophage-conditioned medium went as high as 
483 ppm (5.52 mmol/L) for SZS coatings, which is significantly higher than that of the HA 
coatings (only 0.75 ppm) (as shown in Table 1), and resulted in the downregulation of TNFα 
expression and upregulation of IL-6. Therefore, it is reasonable to hypothesize that the 
possible mechanism for the downregulated osteoclastogenesis of SZS coatings is 
predominantly due to the released Sr
2+
 ions from the coatings and a subsequent alteration of 
the immune environment. 
The successful osseointegration requires adequate and effective osteoclastic activities. High 
osteoclast activity may result in poor quality de novo bone tissue in terms of mass and density, 
which impedes the loading capacity of implants. Such a phenomenon is not uncommon 
clinically, especially in patients with osteoporosis. The inhibition of osteoclastogenesis may 
help to obtain properly balanced osteoclastogenesis and osteogenesis, extending the 
applications of SZS coated Ti-6Al-4V to patients with low bone mass and density, especially 
those with osteoporosis.  
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4.4 The effects of the modulated immune environment on osteogenesis 
In addition to its effects on osteoclastic activities and osteoclastogenesis, the immune 
environment created by SZS coated Ti-6Al-4V also appears to elicit positive effects on the 
osteogenesis. ALP, OPN and COL1 are early markers of the osteoblast lineage while OCN is 
thought to be pinpointing of a more mature osteoblastic phenotype.
57
 Therefore, it is 
reasonable to observe that ALP, OPN and COL1 were upregulated in the early stage (day-3), 
while OCN was upregulated only in the late stage (day-7). The osteogenic effects may be 
related to the upregulation of BMP2 and VEGF. BMP2 is a member of the transforming 
growth factor family and has a strong osteoinductive effect.
58, 59
 On receptor activation, 
BMP2 transmit signals through SMAD-dependent and SMAD-independent pathways, leading 
to osteoblast differentiation of MSCs.
60
 Macrophages are an important source of BMP2, 
contributing to osteogenesis during bone healing.
5
 In this study, we found that SZS coatings 
significantly upregulated the BMP2 expression by macrophages. BMP2 binds to BMPR2 on 
the cell surface, which leads to the intracellular activation of SMAD5.
60
 Activated SMAD5 
subsequently form a complex with SMAD4, which translocates into the nucleus, where it 
facilitates the expression of distalless homeobox5 (Dlx5).
60
 Dlx5 has been shown to induce 
the expression of Runt-related transcription factor 2 (Runx2), inducing osteogenic 
differentiation of BMSCs.
60
 In addition, VEGF gene expression was also significantly 
upregulated, and its expression has been found to be tightly related and synergistic with that 
of BMP2.
61
 VEGF reportedly enhances BMP2-induced osteogenesis and the inhibition of 
VEGF could block BMP2-induced angiogenesis and BMP4-induced bone formation.
62
 Bone 
matrix deposition within the implants is another key step for the osseointegration. Materials 
enhancing osteogenesis would be of great significance in improving the quality of de novo 
bone by increasing its mass and density. 
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As profibrotic cytokines, TGF-βs were found to be highly expressed in a wide range of 
fibrous tissues. TGF-βs can promote the fibrosis process via upregulating the synthesis of 
many extracellular matrix (ECM) proteins.
63
 TGF-β1, which induces fibroblast proliferation 
via the fibroblast growth factor 2/extracellular signal-regulated kinases (ERK) pathway, is a 
key cytokine in the fibrosis process.
64
 TGF-β3 plays an important role in ECM production by 
inducing the expression of collagen type 1, fibronectin, laminin, and proteoglycans.
65
 In 
addition, TNFα contributes to fibrosis via the mediator TNFR2, which then acts through 
ERK1/2 to stimulate proliferation of fibroblasts and inhibit collagen degradation.
66
 TNFα was 
also found to activate the ERK-specific mitogen-activated protein kinase pathway, leading to 
the increased production of TGF-β1 in fibroblasts.
67
 We assayed the expression of the 
fibrosis-promoting genes TGF-β1, TGF-β3 and TNFα, which were all significantly 
downregulated, indicating that the SZS coated Ti-6Al-4V created immune environment did 
not enhance inflammatory fibrosis, but was effective and adequate in improving osteogenesis.  
4.5 Bonding strength of the SZS coating 
In addition to its favourable immunomodulatory property, the SZS coating also had a superior 
bonding strength. The bonding strength of bioceramic coatings with titanium is another 
important factor to maintain the effective life spans of the implants, since the high bonding 
strength will provide a stable coating interface without delamination from titanium to support 
functional loading before the coating materials are completely replaced by new bone tissue. 
The bonding strength of HA coatings is generally in the range of 15-25 Mpa. Although the 
HA coated implants have achieved certain clinical success, the bonding strength of HA 
coating on titanic alloy is still not strong enough and may lead to the delamination 
phenomenon in clinical applications. The clinical significance of higher bonding strengths 
cannot be underestimated and the SZS was shown to have a value of 34.3 MPa. This greater 
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bonding strength gives SZS coatings additional potential for clinical applications, since they 
may have longer life span with functional loading.  
Therefore, Ti-6Al-4V coated with Sr2ZnSi2O7 appears to have qualities that make it a 
promising material for orthopedic applications. In addition, the strategy applied in this study, 
which successfully endowed Ti-6Al-4V with immunomodulatory properties by the action of 
the Sr, Zn, Si bioactive elements in Sr2ZnSi2O7, suggests a method of endowing otherwise 
inert biomaterials with immunomodulatory properties that results in a less severe immune 
response (Figure 11). However, further studies are needed to investigate the exact effects of 
bioactive elements with respect to immune response and osteogenesis by means of a systemic 
evaluation. This would provide basic knowledge for wider application of this strategy to 
manipulate the immune response by the use of different combinations of bioactive elements 
with controlled release. 
5. CONCLUSIONS 
In this study, SZS coatings on Ti-6Al-4V containing the bioactive elements Sr, Zn and Si 
have been successfully prepared by plasma-spray method. SZS coating endowed Ti-6Al-4V 
with immunomodulatory properties had the desirable effect of inhibiting the inflammatory 
reaction of RAW 264.7 immune cells. The SZS-induced immune microenvironments 
suppressed osteoclastogenesis and osteoclastic activities but enhanced the osteogenic 
differentiation via BMP2 pathway. In addition, the prepared SZS coatings had good chemical 
stability in phosphate-buffered solutions, and had significantly higher bonding strength than 
that of HA coatings. The excellent immunomodulatory and physicochemical properties of 
SZS coatings suggest that it is is a promising implant material for the orthopaedic 
applications. The strategy of manipulating the immune response by the use of defined 
combinations of bioactive elements, coupled with the controlled release of ions, can be 
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applied to endow these materials with beneficial immunomodulatory properties and improved 
osseointegration. 
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Table 1. The ionic concentrations of medium for SZS and HA coatings at different culture 
conditions. 
Medium conditions 
Culture medium 
immersed 
Macrophage 
conditioned 
Osteoclast 
conditioned Culture time 
Coating Materials SZS HA SZS HA SZS HA 
Ionic 
Concentration 
(ppm) 
Sr 425.10 0.78 483.24 0.51 457.32 0.48 
3 day 
Si 58.86 1.26 61.62 1.29 55.86 1.23 
Zn 39.66 0 44.97 0 43.62 0 
Ca 43.05 60.57 43.89 89.67 43.95 80.43 
Sr 390.39 0.99 408.15 0.75 365.88 0.63 
6 day 
Si 58.53 0.66 59.43 0.54 54.72 0.45 
Zn 39.39 0 42.99 0 40.41 0 
Ca 48.96 53.25 48.81 75.33 47.91 74.79 
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Figure 1. (A) SEM of the solid-reaction synthesized SZS powders; (B) Reconstituted SZS 
particles prepared by sinter-crushing method; (C) XRD of the SZS powders and particles; (D) 
and (E) SEM of the surface and cross sections of SZS coatings on the Ti-6Al-4V substrate; 
(F) XRD of the prepared SZS coatings. 
(A) 
(B) 
(C) 
(D) 
(E) 
(F) 
SZS powders 
SZS particles 
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Figure 2. (A) SEM of the surface of SZS coatings after soaking in phosphate-buffered 
solution; (B) Ionic concentration changes in the solution suggest that the prepared SZS 
coatings have high chemical stability with low dissolution. 
 
 
(B) (A) 
Page 33 of 43 Journal of Materials Chemistry B
Jo
ur
na
lo
fM
at
er
ia
ls
C
he
m
is
tr
y
B
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
15
 Ju
ly
 2
01
4.
 D
ow
nl
oa
de
d 
by
 Q
ue
en
sla
nd
 U
niv
ers
ity
 of
 T
ec
hn
olo
gy
 on
 29
/07
/20
14
 03
:01
:16
. 
View Article Online
DOI: 10.1039/C4TB00837E
  
 
 
 
Figure 3. (A). MTT showing the overall metabolic activity of RAW 264.7 cells after 1 day 
cultured on the suface of coated Ti-6Al-4V. *: Significant difference (P<0.05) of SZS group 
compared with HA group. (B) (C). RAW 264.7 cells after 1 daycultured on the suface of 
coated Ti-6Al-4V,  showing the nuclei and cytoskeleton stained by DAPI and phalloidin with 
FITC respectively. 
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Figure 4. Fold changes of inflammation related genes (A). TNFα, (B). IL1β, (C). IL6, (D). 
IFNγ, (E). OSM, (F). WNT5A, (G). IL10 and (H). IL1ra in RAW 264.7 cells cultured on the 
coated Ti-6Al-4V. (I). TNFα secretion from RAW 264.7 cells cultured on the coated Ti-6Al-
4V detected by ELISA. *: Significant difference (P<0.05). TNFα, IL1β, IL6, IFNγ, and OSM 
are pro-inflammatory cytokines. WNT5A is an indicator of inflammatory response. IL10 and 
IL1ra are anti-inflammatory cytokines. 
 
 
Page 35 of 43 Journal of Materials Chemistry B
Jo
ur
na
lo
fM
at
er
ia
ls
C
he
m
is
tr
y
B
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
15
 Ju
ly
 2
01
4.
 D
ow
nl
oa
de
d 
by
 Q
ue
en
sla
nd
 U
niv
ers
ity
 of
 T
ec
hn
olo
gy
 on
 29
/07
/20
14
 03
:01
:16
. 
View Article Online
DOI: 10.1039/C4TB00837E
  
 
Figure 5. Fold changes of osteogenesis related genes: (A). MCSF, (B). TGFβ1, (C). TGFβ3, 
(D). VEGF, (E). BMP2 in RAW 264.7 cells cultured on the coated Ti-6Al-4V. *: Significant 
difference (P<0.05).  MCSF is an osteoclastogenic cytokines. TGFβ1 and TGFβ3 are 
profibrotic factors. VEGF is an angiogenic and vasculogenic factor. BMP2 is an osteogenic 
factor.  
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Figure 6. Phagocytosis of the coating materials. RAW 264.7 cells were stained by DAPI and 
phalloidin with FITC for the nuclei and cytoskeleton respectively. (A) (B). HA: RAW 264.7 
cells internalized the HA particles, forming a big “bubble” within the cytoplasma, which was 
observed in the majority of the stimulated cells; (C) (D). SZS: this feature was rarely observed 
in the SZS coating stimulating RAW 264.7 cells.  
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Figure 7. (A). Fold changes of osteoclast activities related genes: TRAP, CTSK, CA2, RANK 
and MMP9 in RAW 264.7 cells cultured on the coated Ti-6Al-4V. The upregulation of TRAP, 
CTSK, CA2, RANK and MMP9 indicates higher osteoclast activities. (B). Fold changes of 
osteoclastogenesis related genes: OPG, RANKL, and MCSF by BMSCs stimulated by the 
conditioned medium. *: Significant difference (P<0.05). RANKL and MCSF are 
osteoclastogenic cytokines. OPG is a decoy receptor of RANKL, interrupting the binding of 
RANKL with RANK receptor, thereby inhibiting osteoclastogenesis. 
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Figure 8. Osteogenesis related gene expression (ALP, OPN, OCN, COL1) by BMSCs 
stimulated by the conditioned medium in day 3 and 7. *: Significant difference (P<0.05). The 
upregulation of ALP, OPN, OCN and COL1 indicates better osteogenesis. 
 
Page 39 of 43 Journal of Materials Chemistry B
Jo
ur
na
lo
fM
at
er
ia
ls
C
he
m
is
tr
y
B
A
cc
ep
te
d
M
an
us
cr
ip
t
Pu
bl
ish
ed
 o
n 
15
 Ju
ly
 2
01
4.
 D
ow
nl
oa
de
d 
by
 Q
ue
en
sla
nd
 U
niv
ers
ity
 of
 T
ec
hn
olo
gy
 on
 29
/07
/20
14
 03
:01
:16
. 
View Article Online
DOI: 10.1039/C4TB00837E
  
 
  
Figure 9. (A). Western blot analysis of ALP expression by BMSCs stimulated by the 
conditioned medium. (B). Alizarin Red S staining of BMSCs stimulated by the conditioned 
medium with osteogenic supplements. *: Significant difference (P<0.05). 
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Figure 10.  Fold changes of BMP2 signalling pathway genes BMPR1A, BMPR2, SMAD1, 
SMAD5 and SMAD4 in BMSCs stimulated by the conditioned medium. *: Significant 
difference (P<0.05). The upregulations of BMPR1A, BMPR2, SMAD1, SMAD5 and SMAD4 
indicate the activation of BMP2 signalling pathway. 
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Figure 11: Scheme illustration of the modulatory effects of SZS on immune environment and 
the subsequent effects on osteogenesis and osteoclastogenesis. 
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